Subscribe
Back to list

AdventHealth–Central Florida Division

Orlando, FL

AdventHealth Cancer Institute in Central Florida is the state’s largest cancer care provider, diagnosing more cancer patients than any health system in the state. It treats over 21,000 patients annually through a comprehensive network of 17 cancer centers. AdventHealth Orlando is listed among U.S. News & World Report‘s “America’s Best Hospitals” for cancer care, earning excellent marks for patient survival, advanced technologies, patient services and more. AdventHealth Orlando also appears on the publication’s top 20 honor roll, with rankings in 11 clinical categories. Boasting over 250 medical, surgical and radiation oncologists, the AdventHealth Cancer Institute delivers subspecialty programs across over 10 disease sites, ensuring highly specialized care. In addition to whole-person care in infusion, radiation therapy, bone marrow transplants and more, the cancer institute is one of Florida’s most active clinical research sites, conducting more than 325 clinical trials annually with over 80 cancer-dedicated research employees. The institute is also first in the state to offer liver histotripsy for advanced liver cancer, and is expanding its immuno-effector cell program with new CAR T treatments, including the first outpatient CAR T program in Central Florida. It is also first in Florida to launch an innovative AI and genetics program to help patients learn their risk of breast cancer.

Becker's Recognition

AdventHealth–Central Florida Divisionhas been named a Becker's honoree on the lists below.

2025 Winner

Hospital & Health Systems

Hospital and Health Systems With Great Oncology Programs

These organizations have earned national recognition for their work in cancer care. These programs offer leading-edge clinical trials and pioneer research discoveries that expand access to care and enhance patient outcomes.

Oncology

Newsletter

Join the 500,000+
healthcare executives
who start their day with
Becker’s

You can unsubscribe from these communications at any time. For more information, please review
our Privacy Policy.
More Newsletters